Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Army Medical Services, Singapore Armed Forces, Singapore, Singapore.
Eye (Lond). 2023 Apr;37(6):1047-1060. doi: 10.1038/s41433-022-02022-5. Epub 2022 Mar 28.
The XEN45 Gel Stent is a subconjunctival filtering device that has demonstrated promising efficacy. This meta-analysis quantitatively evaluates reported complications and interventions after XEN45 implantation in the treatment of open angle glaucoma (OAG).
Pilot, cohort, observational studies, and randomised controlled trials that included at least ten patients undergoing ab interno or externo XEN45 surgery, with or without phacoemulsification were deemed eligible for inclusion. A meta-analysis of proportions with random-effect models was performed using the meta routine in R version 3.2.1. Outcomes included the rate of complications and post-operative interventions.
One hundred and fifty-two studies were identified on initial literature search and 33 were included in final analysis. Numerical hypotony was the most common post-operative complication, involving 20% of patients (95% CI: 10-31%). Post-operative gross hyphema occurred in 14% (95% CI: 7-22%) and transient intra-ocular pressure (IOP) spikes (>30 mmHg) in 13% (95% CI: 4-27%). Stent exposure occurred in 1% (95% CI: 0-2%). Stent migration occurred in 1% (95% CI: 0-3%). XEN45 revision and/or a second XEN45 implantation was performed in 5% of patients (95% CI: 3-7%). Stent relocation was performed in 3% (95% CI: 1-7%). A second glaucoma procedure was performed in 11% (95% CI: 8-15%). 26% underwent one (95% CI: 17-36%), 13% underwent two (95% CI: 5-24%) while 4% underwent three (95% CI: 2-6%) bleb needling procedures. 35% of patients (95% CI: 29-40%) required at least one needling. The average rate of needling per patient was 0.38 (95% CI: 0.20-0.59). However, there is a lack of high-quality data, with 8 of the 33 studies assessed to have a moderate to high risk of bias.
While literature suggests that XEN45 Gel Stent implantation is safe in the treatment of OAG, the overall current level of evidence is low and further studies are needed. More than a third of patients require at least one post-operative bleb needling procedure.
XEN45 凝胶支架是一种眼结膜下滤过装置,已被证实具有良好的疗效。本荟萃分析定量评估了 XEN45 植入术治疗开角型青光眼(OAG)后报告的并发症和干预措施。
纳入至少 10 例接受 XEN45 内或外植入术的患者,包括前瞻性研究、队列研究、观察性研究和随机对照试验,无论是否联合白内障超声乳化术。采用 R 版本 3.2.1 中的 meta 程序对随机效应模型的比例进行荟萃分析。研究结局包括并发症和术后干预的发生率。
初次文献检索共发现 152 项研究,最终纳入 33 项研究进行分析。术后数值性低眼压是最常见的并发症,发生率为 20%(95%可信区间:10-31%)。术后发生明显眼内出血的占 14%(95%可信区间:7-22%),一过性眼压(IOP)升高(>30mmHg)的占 13%(95%可信区间:4-27%)。支架暴露的发生率为 1%(95%可信区间:0-2%)。支架移位的发生率为 1%(95%可信区间:0-3%)。5%(95%可信区间:3-7%)的患者接受了 XEN45 翻修或再次植入。3%(95%可信区间:1-7%)的患者接受了支架再定位。11%(95%可信区间:8-15%)的患者接受了第二次青光眼手术。26%(95%可信区间:17-36%)的患者接受了一次,13%(95%可信区间:5-24%)的患者接受了两次,4%(95%可信区间:2-6%)的患者接受了三次眼周针刺抽吸术。35%(95%可信区间:29-40%)的患者至少需要一次针刺抽吸术。平均每位患者的针刺抽吸术次数为 0.38(95%可信区间:0.20-0.59)。然而,由于文献质量较低,8 项研究被评估为具有中等到高度偏倚风险,目前整体证据水平较低,需要进一步研究。超过三分之一的患者需要至少进行一次术后眼周针刺抽吸术。